WSJ What’s News · The Wall Street Journal

Trump’s Iran Speech Disappoints Markets

·13 min·1 clip
President Trump threatens to hit Iran 'extremely hard' and predicts stock prices will rapidly rebound.
Host Luke Vargas opens the April 2nd AM edition by flagging President Trump's address to the nation the previous evening, defending the ongoing war in Iran and arguing that economic disruptions would be short-lived. Shelby Holliday, the Journal's national security correspondent, provides detailed analysis, identifying the timeline question as the central point of confusion Trump tried to address. Trump distanced the conflict from the lengthy engagements in Afghanistan and Iraq, argued military objectives are nearly complete, and threatened major additional strikes within two to three weeks. He praised Gulf states including Saudi Arabia, Qatar, and the UAE while signaling that protecting the Strait of Hormuz should ultimately be the responsibility of countries that depend on it for oil exports, not the United States. This ambiguity alarmed Gulf nations who fear a US withdrawal could leave the Strait effectively controlled by Iran, holding their oil exports hostage. Trump argued that once the conflict ends the Strait will open naturally because Iran will want to sell oil to fund reconstruction, and predicted gas prices and stock markets would recover rapidly. Markets were unconvinced: US stock futures slid during the speech, South Korea's KOSPI dropped more than 4%, and oil prices climbed more than 5% in early European trading. ING analysts described Trump's threat of further major strikes as injecting fresh uncertainty into energy markets. South Europe Bureau Chief Marcus Walker analyzed Trump's comments to British media about potentially withdrawing from NATO, noting a 2023 law restricting unilateral treaty exit conflicts with a Justice Department opinion suggesting the president has broad treaty abrogation powers, a contradiction that would likely end up in court. The episode also covers the FDA's approval of Eli Lilly's oral GLP-1 weight loss pill, opening a new front in the pharmaceutical competition in that category, and a Journal analysis finding nursing has emerged as one of the most reliable pathways to middle-class wages for workers without four-year college degrees.
Listen to the show on